Researchers have developed an AI model that analyzes sequences of brain scans to accurately predict tumor recurrence in children with gliomas.

Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy.

Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression.

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers.

The “results demonstrate the feasibility of in-vivo brain navigation using a neurosurgical microrobot, potentially opening ...

Illuccix has gained significant market share due to changes in clinical practice and successful distribution. The company requires minimal capital and is expected to generate very high returns as it ...

Telix Pharmaceuticals' quarterly report shows a strong revenue contribution from its acquired nuclear medicine business RLS ...

Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...

A growing understanding of how “reproductive” hormones sculpt the brain could transform the management of neurological ...

For patients with breast cancer, the brain functional network shows a shift toward a more randomized pattern after neoadjuvant chemotherapy (NAC), with progression of chemotherapy leading to expanded ...